Průběžná zpráva MEMMAT: Metronomická a cílená antiangiogenní terapie pro děti s recidivujícím/progredujícím meduloblastomem

• Title in English: MEMMAT Interim Report: Metronomic and targeted antiangiogenic therapy for children with recurrent/progressive medulloblastoma
• Authors: DEMLOVÁ Regina; MATYŠKOVÁ Šárka
• Year of publication: 2020
• MU Faculty or unit: Faculty of Medicine
• Web: https://www.sukl.cz/modules/evaluation/detail.php?id=40857

Attached files

• 2020-06-01_MEMMAT_Zprava_o_prubehu_11_2019_5_2020.pdf
• 2020-11-30_MEMMAT_Zprava_o_prubehu_KH_5_-_11_2020_signed.pdf

• Description: Clinical Trial MEMMAT, EudraCT number: 2010-023691-33 The clinical trial interim report describes the course and current status of the clinical trial (KH) in a defined period. It includes information on document updates, changes in KH centers and examiners, an overview of previously included/completed subjects of evaluation, and detected protocol violations. It also contains information on investigational medicine (reporting serious adverse events, suspicions of serious (unexpected) adverse events, or new findings in relation to safety and efficacy), new measures taken, and audits performed.

Related projects

• Český národní uzel Evropské sítě infrastruktur klinického výzkumu (CZECRIN)